Introduction
Previous studies from this laboratory have used the incorporation of radioactive iron into red cell hemoglobin in male mice as a measure of benzene toxicity (1) (2) (3) . Since benzene inhibited neither hemoglobin synthesis nor the maturation of reticulocytes to erythrocytes, the extent of 59Fe uptake was used as a measure of proliferation of bone marrow erythroid cells. Using this technique, we demonstrated that the ability of benzene to retard bone marrow function could be manifested as a decrease in 59Fe uptake.
Recent studies by Eastmond et al. (4) showed that treating animals with combinations of phenol and hydroquinone, which are two metabolites of benzene, produced decreases in bone marrow cellularity similar to those produced by benzene. We decided to investigate the effects of benzene metabolites, both singly and in combination, on 59Fe uptake in mice, to determine whether similar effects were observed using this indication of marrow function and to extend the range of compounds studied. Thus, we also studied effects of toluene, catechol, muconaldehyde, and p-benzoquinone. Methods 59Fe uptake was measured using a modification of the method of Lee et al. (1, 2 
Results and Discussion
Transit time between the progenitor cells (pronormoblast, normoblast, reticulocyte and erythrocyte) is 24 hr for each stage in the mouse. We had previously reported that the pronormoblast was the most susceptible form to benzene, and the normoblast was also susceptible, but under these experimental conditions no effects were observed on the reticulocyte or the erythropoietin responsive stem cells (1) (2) (3) . By focusing treatment around a point 48 hr prior to administering the iron, we could concentrate on the effects of the benzene metabolites on the pronormoblast.
In these studies, unlike those of Lee et al. (1) (2) (3) , female mice were used and all treatments were given IP, several controls were required. Benzene was given IP 24 hr prior to iron and no effect was observed on 59Fe uptake, confirming that benzene inhibited neither hemoglobin synthesis nor the maturation of the reticulocytes (data not shown). However, Figure 1 shows that when given 48 hr prior to measuring 59Fe uptake, benzene produced a dose-dependent decrease in erythroid cells. As shown previously in male mice (3) , toluene, which is a competi-
Effect of benzene on 59Fe uptake into erythrocyte hemoglobin in female mice and its alteration by toluene. The ordinate represents the percent of the administered dose of 59Fe found in circulating red cells 24 hr after IV administration. Column A, 59Fe uptake in control animals given corn oil; columns B and C, effects of benzene given at 150 and 300 mg/kg, toluene coadministered with 150 mg/kg, respectively, column D, effect of 300 mg/kg toluene coadministered with 150 mg/kg of benzene, and colume E, effect of 600 mg/kg toluene coadministered with 300 mg/kg benzene.
tive inhibitor of benzene metabolism, protected against benzene toxicity. Phenol given alone had little or no effect on 59Fe uptake. Figure 2 shows that hydroquinone also inhibited 59Fe uptake. Figures 3A and 3B show that phenol potentiates the reduction in 59Fe uptake produced by hydroquinone.
Catechol, given alone, had little or no effect on 9Fe uptake. Figure 4 shows that when given with phenol, 59Fe uptake was decreased. The former confirms the results of Eastmond et al. (4) , and the latter suggests that this is a general phenomenon regarding the effect of phenol on dihydroxybenzenes.
It is suggested that this effect results from the free radical oxidation of phenol to phenoxy radical, which in turn oxidizes hydroquinone in two steps to form p-benzoquinone, which may be closer to the ultimate toxic agent than hydroquinone. Figure 5 shows the effect of p-benzoquinone on 59Fe uptake. The effect is achieved at doses in the range of 1 to 5% of the doses of hydroquinone. It is important to note that toluene was not effective in protecting against hydroquinone or p-benzoquinone, suggesting that cytochrome P-450 was not involved in these steps.
Muconaldehyde, a ring-opened product of microsomal benzene metabolism, was also effective in reducing 59Fe uptake in the low milligram dose range (Fig. 6 ). The most striking observation, however, was that when given in combination with hydroquinone, at doses that did not reduce 59Fe uptake when given alone, i.e., 1 mg/kg of muconaldehyde and 50 mg/kg of hydroquinone, a dramatic decrease in 59Fe uptake was observed, and complete cessation was observed at 2 mg/kg of muconaldehyde and 50 mg/kg hydroquinone (Fig. 7) . These observations suggest that exceedingly low doses of benzoquinone and muconaldehyde are effective in reducing bone marrow function. They also indicate that it is likely that benzene toxicity is the result of an interactive effect of benzene metabolites. Their effects may occur at a variety of targets in the cell.
To determine the effect of benzene on DNA as a target, the 32P-postlabeling method (8) was applied to bone marrow DNA isolated from benzene-treated rats (1 mL/kg). The separation of the postlabeled nucleotides is shown in Figure 8 . The single peak following the deoxyadenosine monophosphate standard is more hydrophobic than any of the normal nucleotides, hence, the longer retention time. This suggests that is is larger and bulkier, with perhaps additional rings. T R E A T M E N T The indication that p-benzoquinone is a more potent suppressor of 59Fe uptake is consistent with the fact that p-benzoquinone can exist as an electrophilic resonance form, which could directly react with the critical biomolecules such as DNA, RNA, and enzymic protein. The peak in evidence in Figure 11 indicates that covalent binding to DNA occurs in vivo. The indication that other targets are involved is the suggestion by Irons and Neptun (9,10) that tubulin may be a significant target for benzene metabolites as well as the report by Schwartz et al. (11) pinpointing DNA polymerase as a site at which hydroquinone may react. Furthermore, Rushmore et al. (12) showed that DNA was an important target for benzene metabolites in mitochondria in vitro. The combined impact of benzene metabolites on these key cellular sites may be the ultimate cause of failure of bone marrow cells to proliferate under the influence of benzene. This work was supported by ES 02931.
